Abstract : The sleeve gastrectomy was initially developed as the initial step in the gastric bypass procedure, it is now being carried out on its own an increasing amount. As a result, it is essential to report results on the reduction in the number of co-morbidities as well as weight loss. A continuous group of 80 patients diagnosed with morbid obesity were examined. The operative variables, the number of complications, the amount of weight loss, and the requirement for medication to treat co-morbidity at least six months after surgery were the parameters. The median amount of time spent operating a machine has come down to 74 minutes. The typical length of stay in the hospital was three days. The duration of the follow-up, on average, was 9 months. The typical amount of excess weight lost was 45.5 percent of total body weight. The average number of points off of one's BMI was 24.4 percent. Three quarters of the patients were able to reduce the amount of medication they were taking for diabetes, hypertension, and high cholesterol, or stop taking it altogether. The findings of this study demonstrated that the laparoscopic sleeve gastrectomy is a technique that is beneficial in assisting patients in achieving their weight loss goals. The reduction or cessation of medication in seventy-five percent of the patients was clinically significant.